University of Geneva Scientist Selected for 2024 Rising Stars of Separation Science Award for Excellence in Biopharmaceutical Analysis

Amarande Murisier has earned recognition in the field of biopharmaceutical separation sciences with method development of SEC and IEC hyphenated with MS.

Amarande Murisier is the 2024 Award winner of LCGC International’s Rising Stars of Separation Science Award for Outstanding Achievement in Biopharmaceutical Analysis, sponsored by Agilent Technologies. The award was presented on October 7, 2024, at the 34th International Symposium on Chromatography in Liverpool, United Kingdom.

The inaugural Rising Stars of Separation Science Awards celebrate exceptional achievements in separation science by early career researchers, fostering the next generation of innovators in the field. The awards are divided into four categories: Gas Chromatography (GC), Liquid Chromatography (LC), Biopharmaceutical Analysis, and Pharmaceutical Analysis. Murisier was chosen by an independent panel of experts in biopharmaceutical analysis, chaired by Simone DiMartino from the University of Edinburgh.

Murisier obtained her Ph.D. from the University of Geneva in 2022, where her thesis, titled “Development of Liquid Chromatographic Techniques and their Possible Hyphenation to Mass Spectrometry for Therapeutic Protein Characterization.” Her research focuses on improving liquid chromatographic (LC) methods, which are essential tools for separating, identifying, and quantifying complex biological molecules. Specifically, her work aimed at working to techniques such as size exclusion chromatography (SEC) and ion exchange chromatography (IEC), improving efficiency by coupling with mass spectrometry (MS) for precise protein characterization.

She has earned recognition in the field of biopharmaceutical separation sciences with method development of SEC and IEC hyphenated with MS. She also made a major contribution to pioneering work in developing ultra short columns for biopharmaceutical analysis.In 2023 she joined the clinical pharmacology group at the University Hospital of Lausanne, Switzerland (CHUV), developing, among other things, techniques for quantifying antibodies in the patient’s blood. Since September, serves as an Analytical Lab Manager at Merck, in charge of a team of scientists and technicians dedicated to method development and routine assay analysis to support early-phase pipeline. Murisier has published several fundamental papers on separation techniques for biopharmaceuticals, as well as application-oriented articles.

Investing in the growth of young scientists not only strengthens the scientific community, but also cultivates a culture of collaboration, diversity, and excellence. LCGC International and Agilent are proud to champion the next generation of researchers as they lay the groundwork for future breakthroughs, driving progress in both fundamental and applied science.